Reframing cancer cachexia: the vagal brain-liver axis as a novel neuro-metabolic target
Signal Transduct Target Ther
.
2025 Nov 11;10(1):370.
doi: 10.1038/s41392-025-02483-6.
Authors
Daoyan Wei
1
,
Xinwen Lin
2
,
Robert S Bresalier
3
Affiliations
1
Departments of Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. dwei@mdanderson.org.
2
Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3
Departments of Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rbresali@mdanderson.org.
PMID:
41219223
PMCID:
PMC12606269
DOI:
10.1038/s41392-025-02483-6
No abstract available
Grants and funding
U01 CA086400/CA/NCI NIH HHS/United States
CA086400/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)